JA PreventNCD General Assembly

The 2026 General Assembly will kick off with a one-day plenary on June 9th highlighting our shared project achievements to date and setting an inspiring tone for the days ahead. On June 10th and 11th, we’ll dive into hands-on workshops, aiming to present insights, exciting results and experiences from activities and pilots within JA PreventNCD, piecing together how the various efforts contribute to the overall objectives of the project.

We’ve also set aside dedicated time for WP-specific meetings, ensuring every team’s unique contributions are recognized and advanced.

Our event will end in a joint plenary session on June 11th, bringing everyone together to celebrate progress and chart the course ahead.

The overall aim of the General Assembly is to contribute to the consortium being able to deliver on the overall objectives of JA PreventNCD:

• improve joint capacities of MSs to plan and implement prevention policies and activities at national, regional, and local levels
• improve the monitoring system for NCDs and their common risk factors
• contribute to reduced inequalities in NCDs
• engage with key actors in the field of NCD prevention, including decision makers, civil society organizations, professionals, the general population, and patients’ groups to facilitate cooperation and joint efforts.

Purpose and expected outcomes of the General Assembly 2026

By June 2026, we are more than halfway into the project. Thus, the purpose of this event is to further drive inspiration and collaboration among project participants, promote high scientific quality and relevance of our work, facilitate effective collaboration within the project, and to ensure project coherence and common understanding of project objectives. The event will also aim to facilitate open discussions on our work, including challenges and opportunities as we start to plan for the final outcomes of the project.

Meeting in person is especially valuable, as it allows for building stronger relationships, exchanging ideas more freely, and fully engaging in networking opportunities that can spark new synergies and enhance the overall impact of our joint efforts.

Specifically, the goal is to:

• Present and reflect on key results: share experiences and lessons learned to strengthen effective implementation
• Joint action – added value: Enhance the added value of joint action by strengthening collaboration across countries, work packages, and partners, and by aligning on the project’s key achievements and dissemination activities
• Way forward: Provide a setting for inspiration and critical reflection regarding the remainder of the project, including exploitation and uptake of results and sustainability. Clear outcomes will be defined, individual results integrated into the project narrative, and sustainability embedded into actions and deliverables.

Topics to be included

At this meeting we really aim to present progress from our exciting results and experience from ongoing activities and pilots from JA PreventNCD. We will also invite representatives from MSs and experts to comment and provide feedback on the work presented.

Since the last general assembly in Katowice, the European Union has launched the Cardiovascular Health plan. JA PreventNCD has a number of important activities supporting this plan, and such activities will be highlighted. The program is not yet finalized, but the following topics are being discussed as part of plenary and/or parallel sessions:

• Presentations on project outputs and success stories
• Key achievements
• Cross-cutting themes on risk factors: Alcohol, Physical inactivity, Nutrition and Tobacco
• Financial management and reporting

Who should attend?

This meeting is open to all partners of the JA PreventNCD consortium, Competent Authorities, Affiliated Entities and Associated Partners. Invitations are in particular directed at, but not limited to, colleagues with a leading role in tasks, subtasks, pilots or other key activities such as reporting.

Invitations are also extended to:

• Members of our External Expert Advisory Board,
• Members of our Youth Advisory Group
• Thematic Coordinators
• Members of the Data Management Board, the Ethics Board and the Publication Board
• Project observers
• Other synergistic EU granted projects

Please remember that the cost of participation is the responsibility of your own institution, and we advise you to also confer with your respective (sub/task) leads.

Registration

Registration details will be shared soon.

Practical information

The General Assembly will take place at the Istituto Superiore di Sanità (ISS), Viale Regina Elena 299, 00161 Rome, Italy.

Rome is a major European hub and is well connected by air and rail, with frequent international connections and extensive local public transport options.

How to reach the venue

By public transport

The venue is located in the Nomentano / San Lorenzo area and can be reached by Rome’s public transport network. The Policlinico metro station (Line B) is nearby, with onward connections across the city.

By train

Rome’s main rail hubs connect the city with destinations across Italy and Europe. From central stations, the venue area can be reached via metro, tram/bus, or taxi.

By plane

Rome is served by two international airports (Fiumicino – Leonardo da Vinci and Ciampino) with frequent connections to European cities.

Further details, including recommended accommodation options and additional local guidance, will be shared closer to the event once the programme and logistics are finalised.

Programme

Below you will find the preliminary programme for the event.

Please note that a downloadable PDF version is available for your reference.

9 June – Plenary in auditorium

10 June – Parallel Sessions

11 June – Parallel Sessions & Plenary Closing Session